Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04294732
Other study ID # HZLEZGCFCANLEKR
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date April 1, 2018
Est. completion date January 1, 2020

Study information

Verified date March 2020
Source Bozyaka Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the orthopedic foot and ankle surgeries, the effects of postoperative popliteal nerve block applied for palliation of pain and local anesthetic agent in two different concentrations (0.166 and 0.250) which were used in popliteal nerve block procedure, will be investigated.


Description:

USG guided popliteal nerve block known to be effective in postoperative pain management in foot and ankle surgical procedures but clinical use of the procedure is not yet widespread. However, the volume and concentration of local anesthetic drugs to be administered is still controversial. The study was designed to be prospective and randomized. Patients will be divided into 3 groups by simple randomization. The results of power analysis (G-power 3.1) revealed that a total of 60 patients were required to be included in the study. Because of that, approximately 20 patients are planned for each group. Spinal anesthesia will be performed in all three groups. During procedure 8 ml saline with 8 ml bupivacaine will be apply to the first group and 8 ml bupivacaine and 16 ml of saline will be apply to the second group. Only spinal anesthesia will be given to the third group without peripheral nerve block. The patients participating in the study will not be informed about which group they belong to, the person who makes the block will not prepare the drug and the person who makes the block, the patient and the nurse will not know which concentration drug applied to which patient. Between two groups duration of motor block, duration of sensory block, post-op analgesia time, mobilization time will be investigate. Also the first pain time, the opioid requirement and opioid dose used will be investigated. Analgesia, duration of analgesia, time and requirement of administered IV analgesics, mobilization time after popliteal nerve block will be investigate. package statistical program SPSS (Statistical Package for Social Sciences version 18) will be used for statistical analysis. The parametrical values from the descriptive values will be given as mean and standard deviation, the non-parametric values will be given as number and percentage or median and min-max value. The suitability of the data to the normal distribution will be evaluated with the Kolmogorov-Smirnov test. One-way ANOVA will be use for the comparison of the quantitative data which is appropriate to the normal distribution. The Tukey HSD test will be used to identify the group that caused the difference. Kruskal Wallis-H test will be used to compare quantitative parameters that do not show normal distribution. Mann Whitney U test will be applied to determine the cause of the difference and chi-square test will be used to compare qualitative data. For the analyzes, the level of significance in the 95% confidence interval was found in p < 0.05.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date January 1, 2020
Est. primary completion date April 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients undergoing orthopedic surgery on foot and ankle and who agreed to participate in the study

Exclusion Criteria:

- Patients with sensitivity to local anesthetic

- Patients who do not want to be included in the study

- Preoperative mobilization and movement limitation

- Patients who are not co-operate, cannot complete questionnaire forms and inquiry forms

- Patients with skin infection at the injection site

- Patients with diabetic neuropathy

- Patients with bleeding disorder / Coagulopathy

- Pregnancy

Study Design


Intervention

Drug:
Bupivacaine
bupivacaine is a local anesthetic drug which is already using in surgical procedures. saline is isotonic solution of which has include %0,9 NACL.
Only spinal anesthesia without peripheral nerve block
Only spinal anesthesia without peripheral nerve block

Locations

Country Name City State
Turkey Hazal Ezgi Çifci Izmir Eyalet/Yerleske

Sponsors (1)

Lead Sponsor Collaborator
Bozyaka Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary pain relief activity of popliteal nerve block within thirty-six hours Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 12th hour. If the numeric rating scale is above 3, it will be considered as pain. Postoperative 12th hour
Primary pain relief activity of popliteal nerve block within thirty-six hours Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 24th hour. If the numeric rating scale is above 3, it will be considered as pain. Postoperative 24th hour
Primary pain relief activity of popliteal nerve block within thirty-six hours Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 36th hour. If the numeric rating scale is above 3, it will be considered as pain. Postoperative 36th hour
Primary pain relief activity of popliteal nerve block within three months Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at first months. If the numeric rating scale is above 3, it will be considered as pain. Postoperative first month
Primary pain relief activity of popliteal nerve block within three months Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at second months. If the numeric rating scale is above 3, it will be considered as pain. If pain persist over 1 month, it will be considered as chronic pain. Postoperative second month
Primary pain relief activity of popliteal nerve block within three months Numeric rating scale will be use for evaluate pain. Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at third months. If the numeric rating scale is above 3, it will be considered as pain. If pain persist over 1 month, it will be considered as chronic pain. Postoperative third month
Secondary Investigate the pain relief activity of different concentrations within thirty-six hours To compare the pain relief activity of bupivacaine at a concentration of 0.166 and 0.250 in popliteal block. Numeric rating scale will be use for evaluate pain Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 12th hour. If the numeric rating scale is above 3, it will be considered as pain. Postoperative 12th hour.
Secondary Investigate the pain relief activity of different concentrations within thirty-six hours To compare the pain relief activity of bupivacaine at a concentration of 0.166 and 0.250 in popliteal block. Numeric rating scale will be use for evaluate pain Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 24th hours. If the numeric rating scale is above 3, it will be considered as pain. Postoperative 24th hour
Secondary Investigate the pain relief activity of different concentrations within thirty-six hours To compare the pain relief activity of bupivacaine at a concentration of 0.166 and 0.250 in popliteal block. Numeric rating scale will be use for evaluate pain Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at 36th hours. If the numeric rating scale is above 3, it will be considered as pain. Postoperative 36th hour
Secondary Investigate the pain relief activity of different concentrations within three months To compare the pain relief activity of bupivacaine at a concentration of 0.166 and 0.250 in popliteal block. Numeric rating scale will be use for evaluate pain Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at first month. If the numeric rating scale is above 3, it will be considered as pain. Postoperative first month
Secondary Investigate the pain relief activity of different concentrations within three months To compare the pain relief activity of bupivacaine at a concentration of 0.166 and 0.250 in popliteal block. Numeric rating scale will be use for evaluate pain Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at second month. If the numeric rating scale is above 3, it will be considered as pain. If pain persist over 1 month, it will be considered as chronic pain. Postoperative second month
Secondary Investigate the pain relief activity of different concentrations within three months To compare the pain relief activity of bupivacaine at a concentration of 0.166 and 0.250 in popliteal block. Numeric rating scale will be use for evaluate pain Numeric rating scale contains 0 to 10 pain scores. 0 means no pain and 10 means maximum pain perception which is described by patient. Numeric rating scale will be apply to patient at third month. If the numeric rating scale is above 3, it will be considered as pain. If pain persist over 1 month, it will be considered as chronic pain. Postoperative third month
See also
  Status Clinical Trial Phase
Recruiting NCT05610969 - Music vs Midazolam During Preop Nerve Block Placement - Part 2 Study On Anxiolytic Options Before Peripheral Nerve Blocks Phase 1/Phase 2
Not yet recruiting NCT03628040 - Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery Phase 3
Completed NCT03326609 - Local Anesthetic Concentration and Nerve Block Duration Phase 4
Not yet recruiting NCT02576015 - The Effect of Continuous Femoral Nerve Block With Modulation of Depth of Anesthesia on Prognosis of Patients Receiving Total Knee Arthroplasty N/A
Completed NCT02374008 - The Analgesic Effect of Combined Nerve Block and Systemic High Dose Glucocorticoid After Total Knee Arthroplasty. Phase 4
Withdrawn NCT01625208 - Supraclavicular Versus Combined Block for Ulnar and Median Distribution Hand Surgery N/A
Recruiting NCT06155903 - Peripheral Nerve Block vs Spinal Anesthesia in Patients With Femur Fracture N/A
Terminated NCT05190302 - Determination of the Sensitivity, Specificity & Receiver Operating Characteristic of Nerve Stimulation Receptor as a Decision-making Tool During US Guided PNB
Terminated NCT02161484 - Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement N/A
Active, not recruiting NCT06357013 - Postoperative Analgesia in Bilateral Knee Arthroplasties
Recruiting NCT06267716 - Pericapsular Nerve Block and Iliopsoas Fascial Plane Block in Hip Surgery N/A
Withdrawn NCT04539730 - Liposomal Bupivacaine in Adductor Canal Blocks (ACB) Phase 4
Withdrawn NCT03385967 - Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block Phase 4
Completed NCT03069677 - Music vs Midazolam During Preop Nerve Block Placement Phase 3